Celestica (NYSE:CLS) Stock Rating Lowered by Wall Street Zen

Key Points

• Wall Street Zen downgraded Celestica from “buy” to “hold,” although the broader analyst consensus remains “Buy,” with a consensus price target of $439.81.
• Celestica reported strong quarterly results, posting EPS of $2.54 versus the $2.29 estimate and revenue of $4.68 billion versus expectations of $4.30 billion; revenue increased 62.4% year over year.
• Insiders sold 356,553 shares worth approximately $135.2 million over the past 90 days, while institutional investors own 67.38% of the company.

Celestica (NYSE:CLS - Get Free Report) TSE: CLS was downgraded by investment analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a research note issued to investors on Saturday.

Other equities analysts also recently issued research reports about the company. Rothschild & Co Redburn initiated coverage on Celestica in a research report on Friday, May 1st. They issued a "buy" rating and a $460.00 price objective for the company. Bank of America restated a "buy" rating on shares of Celestica in a report on Wednesday, July 29th. Weiss Ratings lowered Celestica from a "buy (b)" rating to a "buy (b-)" rating in a research note on Thursday, August 13th. Zacks Research raised Celestica from a "hold" rating to a "strong-buy" rating in a report on Friday, June 26th. Finally, Canadian Imperial Bank of Commerce lifted their price target on Celestica from $480.00 to $500.00 and gave the company an "outperform" rating in a report on Wednesday, July 29th. One research analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Buy" and a consensus target price of $439.81.

Celestica Price Performance

Shares of Celestica stock opened at $298.87 on Friday. The stock has a market capitalization of $34.36 billion, a price-to-earnings ratio of 31.07 and a beta of 2.06. The firm's 50-day moving average price is $333.42 and its two-hundred day moving average price is $335.61. The company has a current ratio of 1.23, a quick ratio of 0.68 and a debt-to-equity ratio of 0.32. Celestica has a 1-year low of $183.66 and a 1-year high of $474.02.

Celestica (NYSE:CLS - Get Free Report) TSE: CLS last posted its earnings results on Monday, July 27th. The technology company reported $2.54 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.29 by $0.25. The company had revenue of $4.68 billion during the quarter, compared to analysts' expectations of $4.30 billion. Celestica had a net margin of 7.16% and a return on equity of 39.96%. Celestica's quarterly revenue was up 62.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.39 earnings per share. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. On average, equities analysts predict that Celestica will post 10.42 earnings per share for the current fiscal year.

Insider Activity at Celestica

In other Celestica news, CFO Mandeep Chawla sold 17,000 shares of the company's stock in a transaction on Monday, June 15th. The stock was sold at an average price of $399.65, for a total transaction of $6,794,050.00. Following the transaction, the chief financial officer owned 82,444 shares of the company's stock, valued at approximately $32,948,744.60. This represents a 17.10% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Robert Mionis sold 98,453 shares of the company's stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $368.99, for a total value of $36,328,172.47. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 356,553 shares of company stock valued at $135,238,444 in the last 90 days. 1.10% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Celestica

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Washington Trust Advisors Inc. bought a new position in Celestica in the second quarter valued at about $28,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in Celestica during the 4th quarter worth about $28,000. Swiss RE Ltd. bought a new stake in Celestica during the 4th quarter worth about $29,000. Cullen Frost Bankers Inc. acquired a new position in Celestica during the 4th quarter valued at about $30,000. Finally, Sittner & Nelson LLC acquired a new position in Celestica during the 4th quarter valued at about $31,000. Institutional investors own 67.38% of the company's stock.

About Celestica

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company's service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source